Skip to Main Content

FDA advisory panel recommends Omicron-containing booster shots

We're live-blogging today's FDA advisory panel meeting on whether and how Covid-19 vaccines should be updated.

Tracking an FDA advisory panel meeting on Covid vaccines in young children

On the agenda of the FDA's advisory panel on vaccines today: whether to authorize Covid-19 vaccines from Pfizer and Moderna for use in young children.

Tracking an FDA advisory panel meeting on Covid-19 vaccines and boosters

On the agenda of the FDA's advisory panel on vaccines today: boosters and the possibility of updating the vaccines to better match circulating SARS-CoV-2 strains.

James Hildreth

In February 2021, President Biden named Hildreth as one of 12 members of the new Covid-19 Health Equity Task Force, charged with developing recommendations for mitigating inequities that have caused communities of color to suffer disproportionately from the pandemic. He’s also an adviser on the FDA advisory panel that in October recommended the vaccine for…

FDA authorizes Merck’s Covid-19 pill, but stresses its use should be limited

The FDA granted emergency authorization to Merck’s molnupiravir, an antiviral pill shown to reduce hospitalization and death in cases of Covid-19, the second such treatment to be authorized.

FDA panel narrowly recommends authorization of first antiviral pill to treat Covid-19

A panel of experts convened by the FDA voted by a slim margin to recommend the agency authorize the Covid treatment developed by Merck and partner Ridgeback Biotherapeutics.

FDA advisory panel recommends Pfizer Covid-19 vaccine be authorized for children

An advisory panel to the FDA voted in favor of authorizing the Covid-19 vaccine made by Pfizer and BioNTech for children between the ages of 5 and 11.

Tracking the FDA advisory panel meeting on Covid-19 vaccines for kids

The FDA’s vaccines advisory committee meets today to review the evidence on the Pfizer vaccine’s safety and efficacy in kids ages 5 to 11. Follow along in a live blog from @HelenBranswell and @matthewherper.

FDA advisory panel votes 19-0 to endorse booster dose of J&J vaccine

Unlike the authorizations for boosters for the Pfizer/BioNTech and Moderna vaccines, no restrictions were put on the J&J booster.

Follow the FDA advisory panel meeting on the J&J Covid vaccine booster

Follow STAT's @HelenBranswell and @matthewherper as they live blog the FDA advisory committee meeting on the J&J Covid vaccine booster.

FDA advisory panel endorses Johnson & Johnson Covid-19 vaccine

STAT reporters will live-blogging an FDA advisory committee’s meeting on Johnson & Johnson's Covid-19 vaccine.

STAT+ Conversations: A conversation on racial health disparities, Covid-19, and vaccine distribution

STAT's Nicholas St. Fleur sits down with James Hildreth of Meharry Medical College to discuss racial health disparities and Covid-19.

FDA advisory panel endorses Moderna’s Covid-19 vaccine, clearing way for authorization

An expert panel is meeting Thursday to consider whether the FDA should issue a second emergency use authorization for a Covid-19 vaccine, this one made by Moderna.

Why this week’s meeting of an FDA advisory panel on Covid-19 vaccines matters

It's dry. It's technical. But if you care about Covid-19 vaccines, you may want to tune in.

Two Black university leaders urged their campuses to join a Covid-19 vaccine trial. The backlash was swift

The episode illustrates the challenges historically Black universities face as they seek to leverage their legacies of trust within African American communities to bolster lagging Black enrollment in Covid-19 trials.